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ABSTRACT
To extend the frontier of genome editing and en-
able editing of repetitive elements of mammalian
genomes, we made use of a set of dead-Cas9 base
editor (dBE) variants that allow editing at tens of
thousands of loci per cell by overcoming the cell
death associated with DNA double-strand breaks and
single-strand breaks. We used a set of gRNAs target-
ing repetitive elements––ranging in target copy num-
ber from about 32 to 161 000 per cell. dBEs enabled
survival after large-scale base editing, allowing tar-
geted mutations at up to ∼13 200 and ∼12 200 loci in
293T and human induced pluripotent stem cells (hiP-
SCs), respectively, three orders of magnitude greater
than previously recorded. These dBEs can overcome
current on-target mutation and toxicity barriers that
prevent cell survival after large-scale genome engi-
neering.
INTRODUCTION
Endogenous transposable elements (TEs) such as Alu (1),
long interspersed elements-1 (LINE-1) (2–4) or human en-
dogenous retro viruses (HERV)(5) make up ∼45% of the
human genome (5). While originally characterized as ‘junk
DNA,’ TEs are now recognized as having shaped the evolu-
tion of the human genome, and their residual transposition
activity has been linked to human physiology and disease.
For instance, LINE-1 sequences (17% of the genome) are
highly active in certain somatic cells (6), can disrupt gene ex-
pression (4) and are suspected of having roles in human dis-
eases (2–3,7–8) and aging (9,10). Alu and HERV have been
associated with aging (11) and multiple sclerosis (12,13), re-
spectively. The most direct test of such hypotheses would in-
volve genomically inactivating these elements, but this has
been effectively out of reach because it would require edit-
ing large numbers of distinct loci, challenging the capacity
of current editing methods and the ability of cells to tolerate
their activity due to the high toxicity of double-strand DNA
breaks (DSBs) (14,15). The current record for simultane-
ous inactivation of TEs––62 elements––was achieved us-
ing CRISPR/Cas9 (16) on porcine endogenous retroviruses
(PERVs) in a transformed pig cell line. Two years later a live
pig was born with genome-wide KO of all 25 PERVs (17).
CRISPR/Cas9 incurs toxicity because it generates
double-strand DNA breaks (DSBs) (14). These DSBs con-
tribute to its high genome-editing efficiency by potently
triggering endogenous processes that repair them with
non-random (18,19) or user-specified variations, but high
numbers of concurrent DSBs overwhelm these processes
and cause cell death. Recently, however, two types of
CRISPR/Cas9 ‘base editors’ (BEs) were developed (Sup-
plementary Table S1) by fusing variants of Cas9 that are
either ‘dead’ (dCas9; both nuclease domains inactivated)
or ‘nicking’ (nCas9; one nuclease domain inactivated), in
which the DSB-generating nuclease domains are disabled,
to a nucleotide deaminase. Cytidine base editors (CBEs: ei-
ther dCBEs or nCBEs (20)) employ cytidine deaminases
and convert C:G base pairs to T:A, while adenine base
editors (ABEs: either dABEs or nABEs (21)) use adenine
deaminases and convert A:T base pairs to G:C. Using prop-
erly designed gRNAs, C→T conversions may be used to
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generate stop codons to knock-out protein coding genes of
interest (14). The target nucleotide must be within the edit-
ing window of base three to nine of the gRNAs to be ef-
ficiently edit. Random genome-wide off-target SNVs have
been reported when using CBEs that appear to be indepen-
dent of gRNA binding sites (22,23), additionally RNA off-
targets have been reported when using BEs (24,25). In ad-
dition to off-target mutations, base editors will often deam-
inate adjacent bases to the intended target, limiting the ap-
plications of these tools to when additional base alteration
is tolerated or not possible. Improvements in base editing
purity––the frequency of desired base conversion within
target window––have been achieved by fusing bacterial mu-
gam protein to the base editor to generate nCBE4-gam (26).
Naming conventions for all BEs are summarized in Supple-
mentary Table S2.
To achieve similar efficiencies to native Cas9 all base ed-
itor generations beyond the first are nBEs. As a result, base
editing has been broadly demonstrated with high efficiency
in a range of species including human zygotes (27). A main
motivation for developing BEs that avoid DSBs was to re-
duce the level of random versus user-specified mutations
caused by ‘live’ Cas9, but the reduced toxicity of BEs ac-
crued by avoiding DSBs has also facilitated the editing of
single targets in sensitive cell types such as human induced
pluripotent stem cells (hiPSCs) (28) and up to 20 copies in
pigs (29). However, whether these BEs can enable concur-
rent editing in human cells of sites as numerous as high copy
TEs has not been explored but is particularly relevant to
genome wide recoding efforts such as genome project write
(30) (GP-write). While single-strand breaks (SSBs) are less
toxic and more readily repaired than DSBs, two adjacent
nicks in complementary strands leads to DSBs (31) that
are not readily repaired (32). To recode the human genome
would require an estimated 4438–9811 precise modifica-
tions to remove all instances of one of the three stop codons
(33), while individual delivery of thousands of gRNAs is
out of scope for this manuscript; we separate the challenge
of multiple gRNA delivery by using a single gRNA target-
ing high copy number elements to select the best available
genome editing tools and determine the maximum DNA
edits that can be currently tolerated.
MATERIALS AND METHODS
Transposable element gRNA design
gRNAs targeting Alu were designed by downloading
the consensus sequence from repeatmasker (http://www.
repeatmasker.org/species/hg.html). LINE-1 gRNAs were
designed based on the consensus of 146 ‘Human Full-
Length, Intact LINE-1 Elements’ available from the L1base
2 (34). HL1gR 1–6 were designed to generate stop codons
from C→T deamination mutations. EN, RT and ENRT
pairs of gRNAs were designed to create moderate size dele-
tions (200–800 bp) easily distinguishable from their wild-
type full-length forms by gel visualization. HERV-W gR-
NAs were designed based on the consensus sequence of the
26 sequences identified by Grandi et al. (35) that can lead
to the translation of putative proteins.
qPCR evaluation of copy number across repetitive element
targeting gRNAs
The quantitative polymerase chain reaction (qPCR) reac-
tions were performed using the KAPA SYBR FAST Uni-
versal 2× qPCR Master Mix (Catalog #KK4602) accord-
ing to the manufacturer’s instructions. The LightCycler 96
machine from Roche was used to perform the qPCRs and
the results were extracted using the LightCycler 96 SW
1.1 software. The following thermocycling conditions were
used: ‘preincubation’ stage = 95◦C for 180 s; ‘2-step cycling’
stage: annealing = 95◦C for 3 s and elongation = 60◦C for




P1(b) REBE F TAGGAACAGCTCCGGTCTACA;
P1 REBE-ilu R AATGCCTCGCCCTGCTTCGG; P5
REBE-ilu F CCAATACAGAGAAGTGCTTAAAGG;
P5 REBE-ilu R CTTGGAGGCTTTGCTCATTTCT;
P7 REBE-ilu F CCCATCAGTGTGCTGTATTCAGG;
P7 REBE-ilu R GGCCTTCTTTGTCTCTTTTG;
P13 REBE-ilu F AACAGGCTCTGAAATTGTGGC;
P13 REBE-ilu R GCTGGCCTCATAAAATGAGTTA
G; P15 REBE-ilu F GTTCTGGCCAGGGCAATCAG;
P15 REBE-ilu R CCTGAGACTTTGCTGAAGTTGC
Bioinformatic alignment and copy number analysis
Fasta sequences of hg38 reference genome were down-
loaded from Ensembl (ftp://ftp.ensembl.org/pub/release-95/
fasta/homo sapiens/dna/). Alignment analysis of the gRNA
sequences to all chromosomes was performed using the R
library Biostrings v2.40.2 and plotted using the R library
ggplot2 3.3.0.
SpCas9 and gRNA plasmids used for genome editing
The following Cas9 plasmids were used: pCas9 GFP
(Addgene #44719), hCas9 (Addgene #41815). Base
editing plasmids used: pCMV BE3 (Addgene #73021),
pCMV BE4 (Addgene #100802), pCMV BE4-gam (Ad-
dgene #100806), ABE 7.10 (Addgene #102909). The
gRNAs used in this study were synthesized and cloned
as previously described (36). Briefly, two 24mer oligos
with sticky ends compatible for ligation were synthesized
from IDT for cloning into the pSB700 plasmid (Addgene
Plasmid #64046).
SaCas9 and gRNA plasmids used for genome editing
Cas9 plasmid: pX600-AAV-CMV::NLS-SaCas9-NLS-
3xHA-bGHpA (Addgene #61592). Base editing plasmid:
SaBE4-gam (Addgene #100809). The gRNAs used in this
study were synthesized and cloned as previously described
(37). Briefly, two 24mer oligos with sticky ends compatible
for ligation were synthesized from IDT for cloning into the
BPK2660 plasmid (Addgene Plasmid #70709).
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Maintenance and transfection of HEK 293T cells
HEK293T cells were obtained from ATCC with verifica-
tion of cell line identification and mycoplasma negative re-
sults. They were expanded using 10% fetal bovine serum
(FBS) in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM) with glutamax passaging at a typical rate of 1:100
and maintained at 37◦C with 5% CO2. Transfection was
conducted using Lipofectamine 2000 (Thermofisher Cat-
alogue # 11668019) using the protocol recommended by
the manufacturer with slight modifications outlined below.
Twenty-four hours before transfection ∼1.0 × 105 cells were
seeded per well in a 12-well plate along with 1 ml of me-
dia. A total of 2 g of DNA and 2 l of Lipofectamine
2000 were used per well. For Cas9 plasmids, the DNA con-
tent per well was 1 g of pCas9 GFP mixed with 1 g of
gRNA-expressing plasmid. For BE plasmids, 1.5 g of BE
was mixed with 0.5 g of gRNA plasmid. In the dBE versus
nBE comparison used to generate Figure 4, Pifithrin- (10
ng/l) from Sigma-Aldrich P4359 (source # 063M4741V,
Batch # 0000003019) and bFGF from Thermo Scientific
(catalog # 13256029) was added to the media 30 min before
transfection and maintained in the first day media change.
FACS single cell direct NGS preparation
To quantify early genetic editing in cells transfected with
Cas9/BE and gRNA expression plasmids, single cells were
sorted and prepared as follows. Two days post-transfection,
single cells were FACS-sorted into 96-well PCR plates con-
taining 10 l of QuickExtract™ DNA Extraction Solution
(Epicentre Cat. # QE09050) per well and genomic DNA
(gDNA) was extracted using the manufacturer’s protocol.
Briefly, the sorted plates were sealed, vortexed and heated
at 65◦C for 6 min then 98◦C for 2 min. The NGS library
was prepared as described later below.
Single cell clonal isolation and sequence verification
Single cells were FACS-sorted into flat bottom 96-well
plates containing 100 l of DMEM with 10% FBSand 1%
Penicillin/Streptomycin per well. Sorted plates were incu-
bated for ∼14 days until well-characterized colonies were
visible, with periodic media changes performed as neces-
sary. To extract gDNA, the cells were first detached using
30 l TrypLE™ Express (Thermofisher Cat. # 12604021)
and neutralized with 30 l growth media. Then, 4 l of
the resulting cell suspension was transferred to 10 l of QE.
Genomic DNA was extracted according to manufacturer’s
protocol, as described previously.
Nested PCR Illumina MiSeq library preparation and se-
quencing
Library preparation was conducted as previously described
(38). Briefly, genomic DNA was amplified using locus-
specific primers (Supplementary Table S3) attached to part
of the Illumina adapter sequence. A second round of PCR
included the index sequence and the full Illumina adapter.
All PCRs were carried out using KAPA HiFi HotStart
ReadyMix (KAPA Biosystems KK2602) according to the
manufacturer’s thermocycler conditions. Libraries were pu-
rified using gel extraction (Qiagen Cat. # 28706), quantified
using Nanodrop and pooled together for deep sequencing
on the MiSeq using 150 paired end (PE) reads.
NGS indel analysis
Raw Illumina sequencing data was demultiplexed using
bcl2fastq. All paired end reads were aligned to the refer-
ence genome using bowtie2 (39) and the resulting align-
ment files were parsed for their cigar string to determine
the position and size of all indels within each read using
a custom perl script (https://github.com/CRISPRengineer/
mutation indel). All indels that were sequenced in both the
forward and reverse reads were summed across all reads and
reported for each sample along with the total number of
reads. Indels within a 30 bp window from the 5′ start of the
gRNA proceeding through the PAM and extending an ad-
ditional seven bp’s (for a 20 bp gRNA) were counted and
summed for each sample.
Dual gRNA deletion frequency NGS analysis
Reads were analyzed for dual gRNA large deletions by de-
tecting sequences in between the gRNAs to indicate the full
length unedited (at least not dual gRNA-edited) and se-
quences beyond the normal wild-type amplicon that only
appear when the deletion has occurred to identify deletion
reads. The custom perl script used for analysis is available
at https://github.com/CRISPRengineer/dual gRNA.
NGS base editing deamination analysis
All paired end reads were aligned to the reference genome
using bowtie2, and the resulting alignment files were con-
verted to bam, sorted, indexed, and variant called using
samtools (40). All SNV data within a 30 bp window from
the 5′ start of the gRNA proceeding through the PAM and
extending an additional seven bp’s (for a 20 bp gRNA) are
reported to analyze the editing window and purity of edit-
ing. The custom perl script used for analysis is available at
https://github.com/CRISPRengineer/deamination report.
Site directed mutagenesis to remove remaining nick from base
editors
We deactivated the remaining nuclease domain of Cas9
from nCBE4 (Addgene #100802), nCBE4-gam (Addgene
#100806), pCMV-ABE7.10 (Addgene #102919), pCMV-
AncBE4max (Addgene #112094) and pCMB ABEmax
(Addgene #112095). Agilent QuikChange XL Site-
Directed Mutagenesis Kit (catalogue # 200517) was used
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Propidium Iodide and Annexin V staining and FACS analysis
Cells were dissociated with TrypLE, diluted in an equal
volume of phosphate-buffered saline (PBS) and then cen-
trifuged at ∼300 g for 5 min at room temperature. We resus-
pended samples into 500 l PBS and half of the cells were
pelleted for later gDNA analysis. The remainder was cen-
trifuged and resuspended into 100 l of Annexin V Binding
Buffer (ref #V13246) diluted into ultrapure water at a 1:5
ratio. Subsequently, we added 5 l of Alexa 647 Annexin V
dye (ref #A23204) and incubated samples in the dark for 15
min. We then added 100 l of Annexin V Binding Buffer
and added 4 l of Propidium Iodide (ref #P3566) diluted
into the Annexin V Binding Buffer at a 1:10 ratio. Samples
were incubated in the dark for another 15 min. Cells were
washed with 500 l of Annexin V Binding Buffer and cen-
trifuged again to be finally resuspended into 400 l of An-
nexin V Binding Buffer. All samples were filtered using a cell
strainer and were run on the LSR 11 using a 70-m nozzle.
Analysis was conducted using FlowJo software.
Karyotype analysis of LINE-1 dBE-edited 293T single cell
clones
Stable HEK 293T edited isolated cell lines (nCBE4-gam,
dCBE4-gam, ABE and dABE) were expanded and kary-
otypically compared with the control groups and the wild-
type HEK 293T. Actively growing cells were passaged 1–2
days prior to sending to BWH CytoGenomics Core Labo-
ratory. The cells were received by the core at 60–80% con-
fluency. Chromosomal count, variances and abnormalities
were investigated.
Whole genome sequencing off-target analysis
The top 293T edited clones used for the karyotype anal-
ysis were expanded and isolated with the 293T popu-
lation frozen before initial transfection (pre293T) along
with a control 293T population expanded for an equiv-
alent amount of time as the other mutant clones se-
quenced(post293T). DNA was extracted using the Qia-
gen DNeasy Blood and Tissue kit (cat-#69506) and were
sequenced using Illumina PE 150 to a depth of ∼30×.
Alignment and variant calling was provided by the Har-
vard Chan Bioinformatics Core, Harvard T.H. Chan School
of Public Health, Boston, MA, USA using an analysis
pipeline based on bcbio framework (https://github.com/
bcbio/bcbio-nextgen). For WGS data, BWA (v0.7.17) was
used to map sequencing reads to the reference human
genome (hg38). We called SNPs and indels using somatic
tumor-normal approach (using a control sample as a nor-
mal, and edited samples as ‘tumor’), and required 3 variant
callers (vardict, v.2019.06.04, mutect2 (from gatk 4.1.2.0),
strelka2, v2.9.10) to confirm a variant to be called (a similar
approach was taken by Zuo et al. (24). In the case of RNA-
seq data, we used STAR (v.2.6.1d) to align reads and RNA-
seq specific gatk-based variant calling pipeline, with param-
eters and filters recommended by GATK best practices for
RNA-seq variant calling (https://software.broadinstitute.
org/gatk/documentation/article.php?id=3891), followed by
filtering out variants at RNA editing sites according to the
RADAR (v.2-20180202) database. We used GATK 3.8 to
call variants in RNA-seq data, because our validation has
shown the superior precision of gatk 3.8 over gatk 4.1.2.0
when using RNA-seq reads. Due to the variability of cover-
age in RNA-seq data, variants were called in a single batch
and only variants called as het, hom or hom ref in all sam-
ples were considered for the downstream analysis. We fil-
tered out variants at sites matching gRNA using bedtools
(2.27.1) and a custom bash script and used R-studio and
ggplot2 for the downstream analysis.
RNA-seq analysis after base editing
293T cells were transfected with HL1gR4 and either nABE,
dABE, nCBE4-gam or dCBE4-gam and cell pellets were
isolated after 48 h for DNA and RNA extraction. DNA was
prepared for targeted amplicon sequencing as previously
described. Cells for RNA-seq were lysed with TRIZOL
(ThermoFisher 15596026) and total RNA was extracted
using Zymo RNA mini prep kit (Zymo R2052). RNA
was quantified using Qubit Fluorometer (ThermoFisher
Q10211) and RNA integrity was confirmed by presence of
two ribosomal bands and absence of degraded smears by
gel electrophoresis. mRNA-seq libraries were prepared us-
ing KAPA mRNA HyperPrep (KAPA KK8580) using 1 g
total RNA. Libraries were pooled and sequenced on an Il-
lumina MiSeq.
RNA-seq analysis of LINE-1 edited living cell lines
The RNA of 293T LINE-1 edited clones (1.37–3.4% deam-
ination by nCas9-CBE4-gam editing) was extracted by
treatment with TRIzol (ThermoFisher Scientific, cat-#
15596018) followed by Direct-zol RNA Kit (Zymo Re-
search, cat # R2072), according to the manufacturer’s in-
structions. All samples were prepared from biological dupli-
cates; the parental culture was divided into two cultures and
passaged once before extraction. A total of 500 ng RNA of
each of the samples, as quantified by Qubit (QubitTM RNA
HS Assay Kit, ThermoFisher Scientific, cat-# Q32852), was
used to prepare the libraries using an NEBNext Direc-
tional RNA Library Prep Kit (New England Biolabs, cat-#
E7765S) in conjunction with the Poly(A) mRNA Magnetic
Isolation Module (New England Biolabs, cat-# E7490),
and following the manufacturer’s instructions. Deamina-
tion frequency in the RNA was analyzed using the standard
deamination analysis pipeline used for genomic DNA. Read
counts were generated by mapping reads to a human ref-
erence genome (GRCh38.p12, using the PRI version from
www.genecodegenes.org) using STAR. Differential gene ex-
pression analysis was performed in EdgeR version 3.24.3:
Lowly expressed genes with less than two counts per million
in two or more samples were filtered out, the libraries were
normalized using trimmed mean of M values (TMM) nor-
malization and differentially expressed genes were identified
by using the exact test on the tagwise dispersion to com-
pare the expression of each of the clones to the control sam-
ple. The Benjamini-Hochberg method was used to adjust
P-values for multiple testing. Multidimensional Scaling dis-
tances were generated by using the plotMDS function of
EdgeR on the filtered and normalized libraries and plotted
using ggplot.
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Maintenance and expansion of human iPSCs
Human iPSCs were cultured with mTeSR medium on tissue
culture plates coated with Matrigel (BD Biosciences). For
routine passaging, iPSCs were digested with TrypLE (Ther-
mofisher # 12604013) for 5 min and washed with an equal
volume PBS by centrifugation at 300 g for 5 min. Digested
iPSC pellets were physically broken down to form a single
cell suspension and then plated onto Matrigel-coated plates
at a density of 3 × 104 per cm2 with mTeSR™ medium sup-
plemented with 10 M Y-27632 ROCK inhibitor (Ri) (Mil-
lipore, 688001) for the first 24 h.
Nucleofection in PGP-1 iPSCs
Thirty minutes prior to transfection media was changed
to mTeSR™ supplemented with Pifithrin- (10 ng/l)
from Sigma-Aldrich P4359 (source # 063M4741V, Batch
# 0000003019); a notable spiky edge colony morphology
was observed similar to when Ri is added. Human iPSCs
were digested with TrypLE for 5 min and the single cells
were washed once with PBS. (CS: 4 × 106, PK: 1 × 106) iP-
SCs were then re-suspended in 100 l of P3 Primary Cell
Solution (Lonza) supplemented with (CS: 13.5 g, PK:
6.75 g) of dABE plasmid, (CS: 4.5 g, PK: 2.25 g) of
gRNA plasmid, and (CS: 2 g, PK: 1 g) of pMax. The
combined cells and DNA were then nucleofected in 4D-
Nucleofector (Lonza) using the hES H9 program (CB150).
The nucleofected iPSCs were then plated onto a single well
of a 6-well Matrigel-coated plate in mTeSR medium supple-
mented with 10 M Ri and Pifithrin- (10 ng/l).
Clonal isolation of PGP-1 iPSCs
96-well plates were coated with Matrigel (BD Biosciences)
at a concentration of 50 l/well. A cloning medium so-
lution of 10% CloneR™ (StemCell Technologies #05888)
and Pifithrin-  (10 ng/l) in mTeSR™ was prepared and
added to the coated wells. Cells were digested using Try-
pLE, which was neutralized by an equal amount of cloning
medium. The cell solution was then centrifuged at 300 × g
for 5 min, the supernatant was aspirated, and the cell pel-
let was resuspended in the cloning medium. The cells were
then passed through a 40-m cell strainer and were FACS-
sorted into (i) individual wells containing warm cloning
medium at a density of 1 cell/well and (ii) 2 × 96-well
PCR plates for direct NGS analysis. To prevent disturbance,
there was no media change during the first 48 h, and the
plates were not removed from the incubator during this pe-
riod. A half-medium change was performed on days 3 and
4 with cloning medium. The growing colonies were mon-
itored and a mTeSR™ medium change was done daily for
the following days until extracting the DNA using Quick-
Extract™ and proceeding with library preparation and
sequencing.
Genomic integration and long-term LINE-1 editing in PGP-
1 iPSCs
The base editor constructs were cloned into the piggybac
dox inducible expression vector PB-TRE-dCas9-VPR (Ad-
dgene #63800) including a puromycin selection marker.
HL1gR4 was cloned into the PB-EF1-MCS-IRES-Neo
PiggyBac cDNA Cloning and Expression Vector (catalog
#: PB533A-2) under a constitutive U6 promoter. A to-
tal of 2 g of piggybac base editor plasmids were trans-
fected with 8 g of super transposase using the nucleofec-
tion conditions described previously. Cells were selected for
puromycin (1g/ml) for 10 days. Cells were then transfected
with 2 g PB-gRNA-HL1gR4 and 8 g of super trans-
posase then selected for G418 resistance for 12 days. Doxy-
cycline (1 g/ml) was added at day 12 to induce expression
of the base editors and begin editing at LINE-1 for 21 days.
Genomic DNA was isolated and analyzed for LINE-1 edit-
ing over the time course then single cell isolation was per-
formed as previously described.
Statistical analysis
Statistical analysis was conducted using the student’s t-
test. Differences were considered significant if P-value was
<0.05. * −0.01 < P < 0.05, ** −0.001 < P < 0.01, *** − P
< 0.001, **** −P < 0.0001.
RESULTS
gRNA design and copy number estimation of transposable el-
ements
To assess the efficiency and toxicity of current editing tech-
nologies as applied to TEs, we designed and tested gRNAs
against Alu, LINE-1 and HERV which vary in copy num-
ber from 30 to >100 000 across the genome (Figure 1A). Alu
and LINE-1 gRNAs were respectively designed on the con-
sensus sequences obtained from repeatmasker (41) (Supple-
mentary Table S4) and on the consensus of 146 full-length
sequences that encodes both functional ORF1 and ORF2
proteins (34). At last, gRNAs against HERV-W, one sub-
family of HERV, were designed on the consensus of pu-
tatively active retro-viruses (35) (Supplementary Table S4).
We performed qPCRs of genomic DNA (gDNA) generated
using consensus sequence-based primers to estimate the rel-
ative abundance in HEK 293T and PGP1 iPSCs (Figure
1A). The copy number of HERV-W, LINE-1 and Alu ele-
ments at the edited sites were respectively estimated at 36, 26
000 and 161 000 in HEK 293T; and 32, 19 000 and 124 000
in PGP1 iPSCs (Figure 1B). The TE’s copy number in HEK
293T is higher than that in PGP1 since the former cells are
largely triploid. We used a complementary bioinformatic
approach as a second estimate of TE abundance by align-
ing our designed gRNAs to the human reference genome
(Figure 1C and Supplementary Figure S1). An example of
gRNA HL1gR4 targeting LINE-1 ORF2 is shown in Fig-
ure 1C. The total number of matches for HL1gR4 allowing
2 bp mismatches is 12 657, about half of our qPCR esti-
mate, with the vast majority having an intact PAM (Figure
1D). Since the reference sequence likely undercounts TEs
because of the well-known problems of assembling, align-
ing and mapping these sequences (42), we base our editing
numbers upon the qPCR copy number estimate and editing
efficiency.




Figure 1. Utilizing high copy repetitive elements for the development
of less toxic DNA editors. (A) A summary of HERV, LINE-1 and Alu.
Representation of TEs with qPCR primer sites shown in red and gRNAs
shown in green. (B) qPCR estimation of LINE-1 copy number per hap-
loid genome across the element compared to single copy number controls
in PGP1 and HEK 293T. Errors bars display standard deviation, n = 3.
(C) Genome wide distribution of HL1gR4. (D) HL1gR4 copy number and
PAM distribution.
High copy-number CRISPR/Cas9 editing induces cellular
toxicity and inhibits survival of edited cells
We transfected HEK 293T cells with plasmids expressing
pCas9 GFP and LINE-1 targeting gRNAs to disrupt the
two key enzymatic domains of ORF-2: endonuclease (EN)
and reverse transcriptase (RT) (Figure 2A and Supplemen-
tary Table S4). Three days after transfection, we observed
indel frequencies at the LINE-1 expected targets ranging
from 1.3 to 8.7%, corresponding to an average of respec-
tively, 339 and 2271 edits per haploid genome in the pop-
ulation (Figure 2B). In accord with previous reports that
this degree of genetic alteration is toxic, we confirmed ∼7-
fold increases in cell death and apoptosis through Propid-
ium Iodide and Annexin V staining (Supplementary Figure
S2). A follow-up time-course experiment provided evidence
that cells that undergo editing at hundreds of loci do not
survive. Here we transfected pairs of LINE-1 gRNAs tar-
geting the EN, RT or both (ENRT) domains. Using pairs
of gRNAs causes large deletions (∼170–800 bp) that can
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Figure 2. CRISPR-Cas9 based genome editing at high copy number repet-
itive elements is detectable but ultimately lethal. (A) Schematic of LINE-1
including the two protein coding genes ORF-1 and ORF-2. Three dual
gRNA deletions were designed to disrupt the EN and RT domains of
ORF-2. (B) LINE-1 gRNAs transfected with Cas9 in 293T. Displayed are
single transfections with 95% confidence intervals for a proportion as the
error bars. (C) Gel image visualizing dual gRNA deletion bands compared
to wild-type control bands.
ure S3A). While samples from day two through five show
clear editing with the expected deletion band sizes (Figure
2C), they were no longer detectable at days 9 and 14 in-
dicating that mutated cells either died out as suggested by
our previous cell death assay or were overgrown by wild-
type cells. Deep sequencing of expected dual gRNA deletion
bands confirmed the LINE-1 gRNA breakpoints (Supple-
mentary Figure S3B). While there were no visible bands at
day 9 and 14, we repeated this experiment and attempted to
isolate clones. After early indications of editing no clones
had detectable mutations at day 12 and beyond (data not
shown) suggesting that any significant level of indel activ-
ity at LINE-1 is toxic or limits growth and clonal isolation.
Single cell analysis confirmed the bimodal editing frequency
(16) with a mean deletion frequency of 47.1% (Supplemen-
tary Figure S4).
nCBE and nABE enable isolation of stable cell lines with hun-
dreds of edits
With the thought that nBEs could help improve the viability
of LINE-1 edited cells, we designed and tested LINE-1 tar-
geting gRNAs (HL1gR1-6 [Supplementary Table S4]) that
generate a STOP codon early in ORF-2 using C→T deam-
ination. When we transfected HEK 293T cells with nCBE3
and each of these gRNAs, we observed levels of deamina-
tion at each target locus that, although small (∼1.07–3.91%)
exceeded levels in mock transfected control cells (Supple-
mentary Figure S5). These same CBE gRNAs could also be
used with ABEs as they contain at least one adenine within
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their deamination window. Above control levels of base
editing were observed in genomic DNA in 4/5 gRNAs for
both nCBE (Supplementary Figure S5B) and nABE (Sup-
plementary Figure S5C). While nABE with HL1gR6 ex-
hibited the highest editing efficiency (4.94% or ∼1290 loci)
three days after transfection, we used HL1gR4 going for-
ward because it had the highest signal-to-background ratio
among the more efficient gRNAs. The HL1gR4 target win-
dow also contained three efficiently coedited C’s, thus offer-
ing a clear signal of directed mutation.
293Ts were transfected with HL1gR4 and either nCBE3
or nCBE4-gam with control samples receiving a non-
targeting gRNA. Two days post-transfection, single cells
displayed an average editing of 1.41% for nCBE4-gam and
3.12% for nCBE3. While single cells were observed with up
to 53.9% C→T deamination, or an estimated 14 000 loci
(Figure 3A), in the highest edited single cell. nCBE3 had
slightly higher mean deamination frequency than nCBE4-
gam at this early timepoint but could not form any sta-
ble clonal population to the day 30 timepoint, suggesting
that nCBE4-gam increased overall cell viability more than
nCBE3 when targeting high copy repeats. Four surviving
cell lines were isolated with deamination frequencies up
to ∼1.37% of LINE-1 or an estimated ∼356 sites (Figure
3B). Data presented in Figure 3C shows both the purity of
the desired deamination products and the editing window.
Clone K was the highest edited stable clonal population and
its targeted C→T mutation frequency from day 11 to 30 was
confirmed.
By subjecting the top edited single cell isolate Clone K
to another round of nCBE4-gam editing (Supplementary
Figure S6A) we detected cells with up to 36.26% C→ T nu-
cleotide conversion on day 2 (Supplementary Figure S6B),
and four living clones were isolated with mutation frequen-
cies ranging from 2.43 to 5.04%––corresponding to about
643–1315 edits (Supplementary Figure S6C). While the
clone with the highest number of deaminated sites did not
grow after a freezing and thawing cycle, the three other cell
lines were stable in culture for a period longer than 30 days,
and were termed ‘Clone K-A5’, ‘Clone K-A2’ and ‘Clone
K-D5’, with respectively 643, 749 and 781 edits, respectively.
This observation of the highest edited clone dying off af-
ter initial detection was observed for all types of editors.
We confirmed nBE activity at the lower copy number target
HERV-W with up to 9.6% average nucleotide conversion at
the population level (Supplementary Figure S7). Due to the
difficulty amplifying and analyzing the Alu target, likely be-
cause of high subfamily polymorphism and short repeat se-
quence (290bp) we proceeded exclusively with LINE-1 tar-
geting gRNAs for the rest of the study. This higher than
normal background polymorphism was also observed at
LINE-1 and HERV-W but much less than with Alu.
To confirm that LINE-1 editing at the genome level was
reflected on the corresponding transcripts we performed
RNA-seq on Clone K, Clone K-D5 and Clone K-A5 and
analyzed the percentage of C→T conversion resulting in a
stop codon in ORF2 in the RNA reads (Figure 3D and Sup-
plementary Figure S8). Theoretically, since most of the ac-
tive LINE-1 subsets should generate transcripts, the pres-
ence of the expected stop codon at the messenger RNA























































































































T3 C4 T5 A6 C7 C8 A9 T3 C4 T5 A6 C7 C8 A9
G 0.3 0.5 0.3 0.6 0.5 0.5 0.7 0.1 0.2 0,0 0.6 0.4 0.3 0.4
A 0.3 0.6 0.4 98.4 1.1 1.1 98.6 0.1 0.1 0.1 98.9 0.9 0.3 99.2
T 98.9 1.1 97.9 0.4 4.4 1.2 0.5 99.6 0.4 99.3 0.2 3.7 0.2 0.3
C 0.4 97.6 1.3 0.4 93.7 97.3 0.2 0.2 99.2 0.5 0.2 95 99.2 0.1
Day 2 Day 30
Control
T3 C4 T5 A6 C7 C8 A9 T3 C4 T5 A6 C7 C8 A9
G 0.3 1.1 0.1 0.8 3.0 1.2 0,7 0.1 0.3 0.1 0.5 0.3 0.3 0.3
A 0.4 0.7 0.5 98 1.5 1.5 98.1 0.2 0.2 0.1 98.8 0.9 0.4 99.2
T 98.953.098.4 0.7 51.2 50.7 0.7 99.5 0.5 99.2 0.2 3.7 0.3 0.3
C 0.3 43.9 0.8 0.2 44 47 0.1 0.2 99 0.6 0.3 97 98.9 0.1
Day 2 Day 30
nCBE4 gam
T3 C4 T5 A6 C7 C8 A9 T3 C4 T5 A6 C7 C8 A9
G 0.3 0.5 0.2 0.9 0.7 0.9 0.6 0.1 0.2 0.1 0.6 0.4 0.3 0.3
A 0.6 0.7 0.4 98.1 1.2 0.6 98.5 0.1 0.1 0.2 98.9 0.8 0.4 99.3
T 98.5 9.9 98.3 0.4 10.8 8.5 0.5 99.5 1.9 99.3 0.2 4.8 1.3 0.3
C 0.6 88.9 1 0.5 87.2 90.1 0.2 0.2 97.7 0.5 0.2 93.9 98 0.1
Day 2 Day 30
Figure 3. nBEs targeting LINE-1 enable survival of stable cell lines with
hundreds of edits. (A) Base editing in HEK 293Ts two days after transfec-
tion comparing nCBE3 versus nCBE4-gam. FACS single cells (n = 72) are
plotted as individual points representing targeted base editing nucleotide
deamination. Red line indicates the median and the blue line the mean. (B)
Single cell live culture growth and stable cell line generation at day 11 and
30. (C) Base editing activity across the CBE target window of ∼3–9. Com-
paring day 2 and 30 for analysis of initial editing activity in the most highly
edited single cell for each condition. Editing efficiency is color coded from
non-edited (blue) to highest editing efficiency (red). (D) LINE-1 deamina-
tion analyzed from either RNA or genomic DNA. SEM’s are displayed as
error bars, n = 2.
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that a higher number of edits in the clones was correlated
with a higher number of stop codons at the RNA level,
suggesting that transcriptionally active LINE-1 subfami-
lies were impacted by the multiplexed editing. In Supple-
mentary Figure S8B the number of RNA reads obtained
through the standard deamination analysis pipeline, aver-
aged over the 20 nt protospacer sequence and normalized
the read counts by dividing by the size of their respective
libraries, are displayed. The numbers of up and down regu-
lated genes are found in Supplementary Figure S8C. Mul-
tidimensional scaling of the gene expression data (Supple-
mentary Figure S8D), where the distance between the sam-
ples corresponds to leading log-fold-changes between the
RNA samples, shows a clear separation between the wild-
type and the three edited samples. While differences in gene
expression were observed, the low level of total LINE-1
editing in these clones prevents us from concluding that
LINE-1 knock-out is responsible for these changes.
Nick-less dBEs enable the isolation of stable cell lines har-
boring up to 13 200 edits
Suspecting that generating single-stranded nicks genome-
wide could lead to cytotoxicity, we decided to inactivate
the remaining HNH nuclease domain of nCas9 by an
H840A mutation in the nCas9 backbone and created a set
of dCas9-BEs including dCas9-CBE4-gam (dCBE4-gam),
dCas9-CBE4 (dCBE4) and dCas9-ABE (dABE). Nick-less
dCas9-BEs were tested on single-locus targets to confirm
their deamination activity and compare them to their nBE
equivalents and the existing dCas9-CBE2 (dCBE2). dCBE4
and dCBE4-gam showed a 2.38- and 2.29-fold improvement
in editing efficiency over CBE2 in 293Ts at day 5, respec-
tively (Supplementary Figure S9). Compared to their nick-
ing counterparts this was a 34.7 or 53.2% reduction in ef-
ficiency, but indel activity was reduced to background lev-
els (Supplementary Figure S9A). dABE retained 40.2% of
nABE’s efficiency at a single locus target while reducing in-
del levels to background (Supplementary Figure S9B).
We then transfected 293T cells with HL1gR4 and either
nCBE4-gam, dCBE4-gam, nABE or dABE and individu-
ally sorted and analyzed the cells for target nucleotide con-
version after 2 days. Single edited cells resulted in an aver-
age editing efficiency of 5.31, 1.45, 6.08, 4.43% target nu-
cleotide conversion for nCBE4-gam, dCBE4-gam, nABE
and dABE, respectively. The top edited single cell had up
to 54.9% deamination with nABE, or 14 300 loci, while we
observed significant reductions to mean target nucleotide
mutation frequency with dCBE and dABE when compared
to their nBE equivalents (Figure 4A). In parallel, single cells
were grown to determine whether viable highly edited clones
could be isolated. The editing efficiency trend reversed in
live cells: dBEs showed a significantly increased deamina-
tion frequency over nBEs (Figure 4B). Remarkably, dABE
produced the highest edited viable clone with 50.61% tar-
geted nucleotide conversion or an estimated 13 200 loci. We
estimate that, in our highest dCBE4-gam edited clone, we
have inactivated 6292 of 26 000 loci or 24.2% LINE-1 se-
quences. Base editors that retain nicking activity only gen-
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Figure 4. dBEs improve survival of highly edited cells with thousands of
edits genome wide. (A) nBE compared to dBE in 293T single cells each
represented as a single data point. Base editing is displayed as either target
C→T or A→G conversion for CBE and ABE, respectively. The red line
indicates the median and the blue line the mean. (B) Live single cell analysis
at day 14 of the same experiment. (C) Deamination frequency over time
comparing dBE to nBE from day one to ten. Error bars represent SEM of
n = 3, ns (not significant), P ≥ 0.05; *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001; by two-tailed Student’s t-test compared to controls.
with our prior experiments in Figure 3B. Results were repli-
cated using another LINE-1 targeting gRNA and similar
trends were observed (Supplementary Figure S10). The iso-
lation of living clones with greater than 6000 edits demon-
strate the required number of stable DNA modifications
needed to achieve whole genome recoding can be altered
within a single transient transfection. While we are only us-
ing a single repetitive element targeting gRNA true recoding
efforts will require thousands of unique guides. Combined
with future improvements in gRNA delivery this data in-
dicates that such recoding efforts in mammalian cells are
practical in terms of DNA toxicity.
The nucleotide composition of all bases in the gRNA
and PAM are displayed for the highest edited clone and
parental 293T control for each BE condition used, show-
ing very low non-specific nucleotide conversions for both
nBEs and dBEs at LINE-1 (Supplementary Figure S11).
The mean single cell mutation frequency was reduced from
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5.32% using nABE to 1.45% using dABE, indicating that
disabling nicking resulted in a 3.67-fold decrease in edit-
ing efficiency at the day 2 timepoint (Figure 4B). Fourteen
days after transfection, dBEs gained a marked advantage
as compared to nBEs in the total number of viable cells,
and mutation frequency of single cells. There was a 14.8-
fold increase in mean editing frequency among surviving
live clones when using dABE compared to nABE (Figure
4B), and a 2.38-fold increase was observed for dCBE4-gam
compared to nCBE4-gam. High base editing purity was ob-
served for both ABEs, while CBEs generated non-intended
bases at the target position. dCBEs significantly reduced
the generation of such non-intended bases at the target po-
sition, in particular dCBE4-gam (Supplementary Figures
S9C and D). No non-specific nucleotide conversion within
the gRNA was detected when targeting LINE-1 (Supple-
mentary Figures S12). During the first three days of editing
the dBEs had lower editing frequency when compared to
nBEs but from day seven, dABE gained a significant edge
over nABE (Figure 4C).
As a proof of concept toward the delivery of multiple in-
dividual gRNAs we transfected cells with pools of up to
nine single locus targeting gRNAs to compare dABEmax
versus nABEmax (Supplementary Figure S13A). Absolute
editing efficiencies of up to 87.7% were observed when using
nABEmax (Supplementary Figure S13B). Combinations of
three, six or nine gRNAs were co-transfected and compared
to their individual transfection efficiencies resulting in no
significant difference observed between nicking and dead
versions at this low level of multiplexing (Supplementary
Figure S13C). When six gRNAs were co-delivered there was
a 78.9 and 78.5% of single gRNA delivery efficiency for
dABEmax and nABEmax, respectively.
HL1gR4 PCR products were analyzed to determine that
only 64.1% of reads had a perfect match for the gRNA,
18.4% had a 1 bp mismatch, 3.2% with two mismatches and
13% with more than nine mismatches (Supplementary Ta-
ble S5), thus most similar off-targets are actually within the
LINE-1 locus. To search for random genome wide deamina-
tion off-target analysis was conducted using whole genome
sequencing and RNA-seq. As previously reported (22,23),
we identified genome wide off-target variants enriched for
C*G→T*A mutations after CBE editing, with dCBE4-gam
at 41.4% above ∼30% for the unedited samples (Supple-
mentary Figure S14). We screened for mutations in p53
and apoptosis genes that may explain the survival advan-
tage of highly edited cells but did not find any obviously
deleterious variants (frameshift, splice site, stop codon). We
also detected off-target deamination at the RNA level at
day 2 (Supplementary Figure S15A-B). No long-term ef-
fects of RNA mutation spectrum were observed in the stable
CBE edited clones after 30–70 days (Supplementary Figure
S15C). Chromosomal integrity analysis was performed for
clones edited at LINE-1 with nABE, dABE, nCBE4-gam
and dCBE4-gam. The karyotype results are shown in Sup-
plementary Table S6 and show that the top edited clones
are not significantly different from control groups in terms
of the total number of aberrations (Supplementary Figures
S16 and 17). Further analysis in a karyotypically normal
and stable cell line is required to fully assess chromosomal








































































Figure 5. Survival cocktail and conditions for clonal derivation of iPSCs
after large-scale genome engineering. (A) Human iPSC transfection time-
line and survival cocktail conditions. (B) Eighteen-hour single cell direct
NGS analysis of dABE targeting LINE-1. CS and PK indicate the two
researchers who conducted the experiments. The red line indicates the me-
dian and the blue line the mean. (C) Live cell colony analysis of surviving
iPSCs at day 11 post-transfection.
dABE allows the isolation of hiPSCs harboring up to 12 200
edits
We next attempted the large-scale genome editing of PGP1
hiPSCs. The survival cocktail and single cell isolation time-
line is shown in Figure 5A. The same experiment was con-
ducted with two slight variations of the electroporation pro-
tocol in terms of total cells transfected and the total amount
of DNA used (CS and PK conditions). Single cells were
sorted and analyzed for target nucleotide conversion fre-
quency 18 h post-electroporation and the average single cell
had 2.09% target A→ G conversion while the highest edited
single cell had ∼6.96% target A→G conversion or ∼1320
sites (Figure 5B). In parallel live single cells were isolated
and stable cell lines formed at 11 days post-transfection.
Colonies were analyzed for targeted LINE-1 A→G nu-
cleotide conversion with a 1.30% and 0.96% mean editing
frequency for CS and PK conditions, respectively, 18 h af-
ter transfection (Figure 5C). At day 11, the median editing
efficiency of the CS live clones was higher than that of PK
live clones in contrast to the value observed at the earlier
time point, suggesting that lower initial editing efficiency
may increase the viability of stably edited cell lines. The aver-
age single cell had 1.21% target A→ G conversion while the
highest edited clone had a nucleotide conversion frequency
of 13.75% which corresponds to 2600 sites genome wide,
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exceeding by three orders of magnitude the number of si-
multaneous edits previously recorded in iPSCs (43). The in-
creased background that occurs in single cell direct analysis
Figure 5B compared to isolation from an expanded colony
Figure 5C is likely due to the necessary over-amplification
required to get enough genomic material from a single cell.
Similar observations were made in previous experiments
using 293T cells. All other previously tested DNA editors
failed to produce any detectable edits at the LINE-1 locus
in human iPSCs which are sensitive to even minor DNA
damage (44) and rapidly deplete cells transfected with Cas9
and TE gRNAs over time (Supplementary Figure S18).
We then integrated a set of six base editors and the
HL1gR4 gRNA using the PiggyBac transposon system
achieve genome editing over time to probe the current limits
of genome editing while targeting LINE-1 (Supplementary
Figure S19A). After doxycycline activation of the base edi-
tors a population average deamination frequency of 17.13%
was observed for dABEmax and 0.78% for dCBEmax with
majority of the editing occurring in the first five days of acti-
vation (Supplementary Figure S19B). All CBEs and nicking
variants were barely elevated above background levels. We
then sorted the dABEmax edited population from day 28
frozen stock for single cell direct DNA analysis of LINE-
1 observing a 13.9% average editing frequency and a top
edited cell at 64.3% or ∼12 200 sites genome wide (Supple-
mentary Figure S19C). We performed a karyotype analysis
of the original PGP1 iPSCs, after PB-dABEmax integra-
tion, and after HL1gR4 editing, all of which were normal
demonstrating that large-scale genome editing can be con-
ducted without gross chromosomal abnormalities (Supple-
mentary Figures S20–22).
DISCUSSION
CRISPR has recently brought about a radical transforma-
tion in the basic and applied biological research, leading to
commercial applications and a multitude of clinical trials
(45), and even to the controversial tests of human germline
modifications (46–50). While the use of CRISPR and its
myriad derivatives has greatly reduced the activation energy
and technical skill required to perform genome editing sev-
eral barriers limit fundamental and clinical applications: (i)
The need for a custom gRNA, for each target, (ii) difficult
delivery, (iii) inefficiencies once delivered, (iv) off-target er-
rors, (v) on-target errors, (vi) the cytotoxicity of DNA dam-
age when multiplexing beyond 62 loci (16), (vii) the limi-
tation of insertion to sizes below 7.4kb (51), (viii) immune
reactions to Cas, gRNA and vector. This study aims to de-
velop tools that address the weakness of excessive cytotox-
icity after large-scale genome editing.
Improving the actual multiplexed eukaryotic genome
editing capabilities by several orders of magnitude holds the
potential of revolutionizing human healthcare. Combina-
torial functional genomic assays would enable the study of
complex genetic traits with applications in evolutionary bi-
ology, population genetics, and human disease pathology.
Multiplex editing has also permitted the development of
successfully engineered cell treatments, such as the chimeric
antigen receptor (CAR) therapies, which require the simul-
taneous editing of three target genes. Future treatments may
require many more modifications to augment cancer im-
munotherapies, slow down oncogenic growth and reduce
adverse effects, such as host-versus-graft disease. Further-
more, customizing host-versus-graft antigens in human- or
nonhuman- donor tissues may require more modifications
than have been made so far, for which the development of
genome-wide editing technologies is needed. Special atten-
tion should be paid to the safety of the editing and its impact
on the functional activity of the transplants, since donor tis-
sues may persist in the patients for decades.
To complete genome-wide recoding and enable projects
such as GP-write ultra-safe cells (30) or the de-extinction
efforts to regain lost biodiversity, safe DNA editors must
be developed to increase the number of genetic modifica-
tions possible by several orders of magnitude without trig-
gering overwhelming DNA damage, as well as overcoming
the delivery of multiple distinct gRNAs per cell, the latter
of which we do not address is this study. C321.A is a mas-
sively modified strain of Escherichia coli MG1655 for which
all instances of the Amber stop codon were replaced (52).
This has ‘freed-up’ an entire codon that can be used for syn-
thetic biology applications such as biocontainment (53), or
the inclusion of synthetic amino acids with novels functions.
To attempt such a feat in the human genome will require the
modification of 4438 Amber codons (33). We have shown
that gene editors that do not cause double- or single-strand
DNA breaks can generate a number of edits sufficient to
theoretically achieve this genome recoding and pave the way
toward making pan-virus resistant human cells. This could
have commercial application toward cell-based production
of monoclonal antibodies, recombinant protein therapeu-
tics and synthetic meat production.
As our study demonstrates, genome-wide disruption of
high copy number repetitive elements is now possible and
opens new opportunities to study the ‘dark matter’ of the
genome. CBEs that allow the generation of STOP codons
within an open reading frame will be a great tool to probe
at the functions of TEs, potentially turning observed as-
sociations with physio-pathological phenotypes into cau-
sations. For instance, large-scale inactivation of HERV-W
and LINE-1 elements could help investigate their respective
roles in multiple sclerosis and neurological processes. When
delivering gRNAs targeting multiple independent loci, an
enrichment in editing competent cells with homozygous ed-
its at all targets was reported (54). While only using a sin-
gle gRNA our distribution highly edited LINE-1 clones
(Figure 4B) suggest that an editing competent cell state ex-
ists that enables up to ∼13 200 base transitions within two
weeks in some small fraction of cells. Further investigation
to identify and manipulate this editing competent state are
warranted.
More in-depth studies will be necessary, however, to as-
sess the impact of this massive editing on normal cell pro-
cesses, since collateral damage may occur. We expect the
thorough on- and off- target analysis at repetitive elements
to remain a difficult task to accomplish due to their high
level of polymorphism; therefore, strong biological controls
as well as new experimental and bioinformatics pipelines
will be needed to overcome such a challenge.
In our study, we observed that dABE increases the viabil-
ity of highly edited clones as compared to dCBE. This dif-
Nucleic Acids Research, 2020, Vol. 48, No. 9 5193
ference may be explained by two factors. First, when using
HL1gR4, CBE has three target nucleotides within its deam-
ination window as compared to one for ABE, and as a con-
sequence, CBE converts three times more nucleotide than
ABE, potentially causing additional cytotoxicity. Second,
when using CBE, the uracil N-glycosylase actively catalyzes
the removal of the deaminated cytosine, generating several
nicks genome-wide that promote DNA damage and poten-
tial cell death. The conversion of adenosine into inosine us-
ing ABE may not be detected as efficiently by the DNA re-
pair machinery, therefore increasing the viability of large-
scale editing. Thus, we anticipate the conditional modula-
tion of DNA repair processes such as mismatch repair or
base excision repair––that trigger downstream single- and
double-strand breaks in the genome––to further improve
the extent of dBEs’ performance.
At last, since dBEs do not generate direct breaks in the
genome, they decrease indel frequency to background and
may not trigger DNA sensors such as p53, while retaining
about 34–53% targeted nucleotide conversion frequencies
as compared to their nBE counterparts. 293T cells have an
impaired p53 response so this isn’t likely the only explana-
tion. We did not observe an increase in apoptotic markers
in our study but an increase in the DNA damage marker
λ-H2AX was observed in cells expressing Cas9 and a repet-
itive element targeting gRNA (55). Another possible mech-
anism for toxicity when nicking near high copy targets is
that they could disrupt RNA expression of essential genes
required for survival. As a consequence, successful genetic
modifications with dBEs may not enrich for pro-oncogenic
cells that have disrupted DNA-damage guardians as has
been reported for Cas9 (56). Even at low levels of multiplex-
ing, this feature may promote dBEs as an essential tool for
therapeutic applications such as gene therapies.
In summary, this work optimized large-scale genome
editing to enable cell viability after the simultaneous editing
of thousands of loci per single cell. The ability to precisely
edit many loci genome wide may facilitate the true poten-
tial of personalized medicine as we further develop our un-
derstanding of gene interactions and epistasis. We envision
these new DNA editors to be combined with further im-
provements in the multiplex delivery of gRNAs to usher in
a new phase of synthetic biology where it is possible to imag-
ine recoding whole mammalian genomes. When combined
with further modulation of DNA repair and pro-survival
factors there may be no limit to the number of bases that
can be modified in a single genome, opening up new av-
enues that previously were thought not possible. We have
overcome the toxicity limitation that prevented large-scale
genome editing in human iPSCs and have expanded the
editing boundary by three orders of magnitude. The con-
tinued development of multiplex delivery along with non-
toxic, high-efficiency DNA editors without DSBs or SSBs
is paramount to the success of genome-wide recoding ef-
forts to probe the inner workings of life, ultimately leading
to the radical redesign of nature and ourselves.
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Key plasmids developed during this study have been sub-
mitted to Addgene: pSB700 HL1 gR4 (# 124450), dABE
(# 124447) and dCBE4-gam (# 124449). All NGS data used
for the figures and supplementary figures have been made
available at SRA BioProject Accession #PRJNA515875,
#PRJNA518077 and #PRJNA561375 for 293T, PGP1 and
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13. Göttle,P., Förster,M., Gruchot,J., Kremer,D., Hartung,H.P.,
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Said,K., Yildiz,R., Dysart,M., Wang,S., Thompson,D. et al. (2020)
CRISPR-mediated biocontainment. bioRxiv doi:
https://doi.org/10.1101/2020.02.03.922146, 04 February 2020,
preprint: not peer reviewed.
56. Ihry,R.J., Worringer,K.A., Salick,M.R., Frias,E., Ho,D.,
Theriault,K., Kommineni,S., Chen,J., Sondey,M., Ye,C. et al. (2018)
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem
cells. Nat. Med., 24, 939–946.
